Interview | Futures in Focus: The Technologies and Strategies Shaping Clinical Trial Supply

The clinical trial supply chain is undergoing a radical transformation. With the complexity of multi-indication treatments and rare disease trials driving new challenges, innovative technologies and strategies are now essential. In this interview, Steve Jacobs, President of Global BioPharm Solutions, LLC, explains how advanced tools and patient-centric approaches are reshaping every link in the supply chain.

Steve discusses how AI, automation, and digital tools are streamlining operations—from accurate forecasting and data collection to efficient drug returns and reconciliation. These innovations not only boost efficiency and data quality but also help overcome challenges like supply kit expiries and comparator shortages. He also highlights the benefits of decentralised, direct-to-patient models that improve enrolment and retention while ensuring regulatory compliance and sustainability.

Download this interview to learn more about:

• Transforming Clinical Supply Chains: AI and automation streamline data collection, enhance forecasting accuracy, and reduce manual inefficiencies to ensure timely supplies and improved operational performance.
• Decentralised Trials & Direct-to-Patient Models: Direct-to-patient approaches address recruitment challenges and complex multi-indication studies, elevating enrolment, retention, and overall supply chain effectiveness.
• Integrated Systems & Sustainability: Scalable, eco-friendly systems overcome packaging, regulatory, and drug return challenges while ensuring global access and robust data integrity.

Embrace the future of clinical trial supply management where cutting-edge technology meets smart, sustainable strategy.